Evaluation of a commercial assay for ADAMTS13 activity measurement

Thrombosis and Haemostasis

Volumn 110, Issue 4, 2013, Pages 852-853

  Thouzeau, Sandrine ^a,b   Capdenat, Sophie ^a   Stepanian, Alain ^c   Coppo, Paul ^b   Veyradier, Agnès ^a,b  

^a HÔPITAL ANTOINE BÉCLÈRE   (France)

^b ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^c HÔPITAL LOUIS MOURIER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

VON WILLEBRAND FACTOR CLEAVING PROTEINASE;

BLOOD SAMPLING; CALIBRATION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLUORESCENCE RESONANCE ENERGY TRANSFER; HELLP SYNDROME; HEMOLYSIS; HUMAN; HYPERTRANSAMINASEMIA; IDIOPATHIC DISEASE; LETTER; LIMIT OF DETECTION; MAJOR CLINICAL STUDY; MEASUREMENT; PRIORITY JOURNAL; QUALITY CONTROL; REPRODUCIBILITY; SENSITIVITY ANALYSIS; SEPSIS; THROMBOCYTE COUNT; THROMBOTIC THROMBOCYTOPENIC PURPURA;

ADAM PROTEINS; BIOLOGICAL ASSAY; BIOLOGICAL MARKERS; CALIBRATION; COLLAGEN; DIAGNOSIS, DIFFERENTIAL; FLUORESCENCE RESONANCE ENERGY TRANSFER; HUMANS; PROTEIN BINDING; REAGENT KITS, DIAGNOSTIC; REPRODUCIBILITY OF RESULTS; RESEARCH DESIGN; SENSITIVITY AND SPECIFICITY; THROMBOTIC MICROANGIOPATHIES;

EID: 84884833432     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH13-05-0393     Document Type: Letter

References (6)

1. Zheng XL, Sadler JE. Pathogenesis of thrombotic microangiopathies. Annu Rev Pathol 2008; 3: 249-277.
2. Tsai HM. Pathophysiology of thrombotic thrombocytopenic purpura. Int J Hematol 2010; 91: 1-19.
3. Kremer-Hovinga J, Lämmle B. Role of ADAMTS13 in the pathogenesis, diagnosis and treatment of thrombotic thrombocytopenic purpura. Hematology Am Soc Hematol Educ Program 2012; 2012: 610-616.
4. Mackie I, Langley K, Chitolie A, et al. Discrepancies between ADAMTS13 activity assays in patients with thrombotic microangiopathies. Thromb Haemost 2013; 109: 488-496.
5. Moatti-Cohen M, Garrec C, Wolf M, et al.; For the French Refrence Center for Thrombotic Microangiopathies. Unexpected frequency of Upshaw-Schulman syndrome in pregnancy-onset thrombotic thrombocytopenic purpura. Blood 2012; 119: 5888-5897.
6. Kokame K, Nobe Y, Kokubo Y, et al. FRETS-VWF73, a first fluorogenic substrate for ADAMTS13 assay. Br J Haematol 2005; 129: 93-100.